This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Meiragtx Gene Regulation Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Susanne Anna Snoek: Innovator in Gene Therapy
Introduction
Susanne Anna Snoek is a prominent inventor based in the Netherlands, known for her contributions to the field of gene therapy. With a focus on developing innovative solutions for treating arthritic diseases, her work has the potential to significantly impact patient care.
Latest Patents
Susanne has developed a notable invention titled "A Modified Raav Capsid Protein For Gene Therapy." This invention relates to recombinant adeno-associated virus (rAAV) virions designed for gene therapy. The rAAV virions incorporate a novel capsid protein, which enhances their effectiveness in treating conditions such as rheumatoid arthritis through intraarticular administration. Currently, she holds 1 patents.
Career Highlights
Susanne is affiliated with MeiraGTx UK Ltd, where she collaborates with a team of experts to advance gene therapy technologies. Her work is characterized by a commitment to innovation and improving therapeutic outcomes for patients suffering from arthritic diseases.
Collaborations
One of her notable collaborators is Dirk Grimm, with whom she works closely to further develop her research and inventions in the field of gene therapy.
Conclusion
Susanne Anna Snoek's contributions to gene therapy exemplify her dedication to advancing medical science. Her innovative work holds promise for improving treatments for arthritic diseases, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile